Volume 13 Supplement 1

Challenges in malaria research: Core science and innovation

Open Access

Structural analysis of mitochondrial cytochrome bc1 complex with atovaquone bound reveals the molecular basis of antimalarial drug action

  • Dominic Birth1, 2,
  • Wei-chun Kao1, 2 and
  • Carola Hunte1
Malaria Journal201413(Suppl 1):P103

https://doi.org/10.1186/1475-2875-13-S1-P103

Published: 22 September 2014

Background

The substituted hydroxynaphthoquinone atovaquone is a potent antimalarial drug in use for prevention and therapy, a fundamental part of the ongoing global medicinal strategy to control the disastrous infectious disease. Atovaquone acts via inhibition of the cytochrome bc1 complex (cyt bc1) and related mutations were linked to parasitic drug-resistance.

Materials and methods

The molecular binding mode of atovaquone was analysed by spectroscopy and X-ray crystallography. In addition, a comprehensive cytochrome b sequence analysis was performed to interpret binding interactions of the drug in context of sequence conservation of Qo site amino acid residues [1, 2].

Results

We determined the 3.0-Å resolution X-ray structure of mitochondrial cyt bc1 from Saccharomyces cerevisiae with atovaquone bound in the catalytic Qo site [1]. The drug, which has a pKa of 6.9, forms a polarized H-bond between its ionized hydroxyl group and His181 of the Rieske protein subunit. Multiple non-polar interactions with side chains of cytochrome b residues stabilize hydroxynaphthoquinone and chlorophenyl-cyclohexyl groups. The cytochrome b sequence analysis showed that the majority of the interacting residues are conserved, so that atovaquone binding to the yeast cyt bc1 is likely to resemble the binding to the complexes of the target organisms.

Conclusion

The binding mode provides detailed insights in the molecular basis of broad target spectrum, species-specific efficacies and acquired resistances. This may aid drug development to control the spread of drug-resistant parasites.

Authors’ Affiliations

(1)
Institute for Biochemistry and Molecular Biology, ZMBZ, BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg im Breisgau
(2)
Faculty of Biology, University of Freiburg, Freiburg im Breisgau

References

  1. Birth D, Kao WC, Hunte C: Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action. Nat Commun. 2014, 5: 4029-View ArticlePubMedGoogle Scholar
  2. Kao WC, Hunte C: The molecular evolution of the Qo motif. Genome Biol Evol. 2014, 6: 1894-10.1093/gbe/evu147.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Birth et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement